Search by Drug Name or NDC
NDC 00409-7335-20 Ceftriaxone Sodium 2 g/1 Details
Ceftriaxone Sodium 2 g/1
Ceftriaxone Sodium is a INTRAMUSCULAR; INTRAVENOUS INJECTION, POWDER, FOR SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Hospira, Inc. The primary component is CEFTRIAXONE SODIUM.
MedlinePlus Drug Summary
Ceftriaxone injection is used to treat certain infections caused by bacteria such as gonorrhea (a sexually transmitted disease), pelvic inflammatory disease (infection of the female reproductive organs that may cause infertility), meningitis (infection of the membranes that surround the brain and spinal cord), and infections of the lungs, ears, skin, urinary tract, blood, bones, joints, and abdomen. Ceftriaxone injection is also sometimes given before certain types of surgery to prevent infections that may develop after the operation. Ceftriaxone injection is in a class of medications called cephalosporin antibiotics. It works by killing bacteria. Antibiotics such as ceftriaxone injection will not work for colds, flu, or other viral infections.Using antibiotics when they are not needed increases your risk of getting an infection later that resists antibiotic treatment.
Related Packages: 00409-7335-20Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Ceftriaxone Injection
Product Information
| NDC | 00409-7335 |
|---|---|
| Product ID | 0409-7335_c89e0cee-3419-4c53-bce1-796a1f911117 |
| Associated GPIs | 02300090102120 |
| GCN Sequence Number | 009164 |
| GCN Sequence Number Description | ceftriaxone sodium VIAL 2 G INJECTION |
| HIC3 | W1Y |
| HIC3 Description | CEPHALOSPORIN ANTIBIOTICS - 3RD GENERATION |
| GCN | 39963 |
| HICL Sequence Number | 003996 |
| HICL Sequence Number Description | CEFTRIAXONE SODIUM |
| Brand/Generic | Generic |
| Proprietary Name | Ceftriaxone Sodium |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Ceftriaxone Sodium |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | INJECTION, POWDER, FOR SOLUTION |
| Route | INTRAMUSCULAR; INTRAVENOUS |
| Active Ingredient Strength | 2 |
| Active Ingredient Units | g/1 |
| Substance Name | CEFTRIAXONE SODIUM |
| Labeler Name | Hospira, Inc |
| Pharmaceutical Class | Cephalosporin Antibacterial [EPC], Cephalosporins [CS] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA065169 |
| Listing Certified Through | 2025-12-31 |
Package
NDC 00409-7335-20 (00409733520)
| NDC Package Code | 0409-7335-20 |
|---|---|
| Billing NDC | 00409733520 |
| Package | 10 VIAL, SINGLE-USE in 1 CARTON (0409-7335-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-USE (0409-7335-21) |
| Marketing Start Date | 2018-03-19 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |